An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial. (2020)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04642-2

PubMed Identifier: 32807214

Publication URI: http://europepmc.org/abstract/MED/32807214

Type: Journal Article/Review

Volume: 21

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215